t(8;21) (q22;q22) Acute myelogenous leukemia in México: A single institution experience
- 1 August 2006
- journal article
- Published by Taylor & Francis in Hematology
- Vol. 11 (4) , 235-238
Abstract
We analyze the prevalence and clinical features of a group of patients with t(8;21) (q22;q22) acute myeloblastic leukemia, identified in a single institution in México over a 10-year period. Fifteen patients presented at the Centro de Hematología y Medicina Interna de Puebla from February 1995 to August 2005; only nine were treated and followed in the institution. Median age was 24 years, (range 7-49); there was only one male. According to the French-American-British (FAB) morphological classification of leukemia, the morphology was M2 in four cases, M4 in three cases, M3 in one case and M0 in one. In addition to the myeloid markers, lymphoid markers were identified in 6 patients. Patients were induced to remission with combined chemotherapy and three subsequently underwent bone marrow transplantation (BMT). The median overall and disease-free survival has not been reached, being above 3390 days, the probability of survival at this time was 73%. In this single-center experience in México, we found that the t(8;21) (q22;q22) variant of leukemia was more frequent than in Caucasian populations, that the co-expression of lymphoid markers in the blast cells is very frequent and that this malignancy is associated with a relatively good prognosis.Keywords
This publication has 13 references indexed in Scilit:
- Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B StudyJournal of Clinical Oncology, 2005
- Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignanciesCytometry Part B: Clinical Cytometry, 2005
- No Preferential Sensitivity of t(8;21) Acute Myeloid Leukemias to Cytosine Arabinoside in Vitro: Is Intensity of Therapy or High Dose Ara-C Crucial for Response?Leukemia & Lymphoma, 2004
- Allogeneic hematopoietic stem cell transplantation with non-myeloablative conditioning in patients with acute myelogenous leukemia eligible for conventional allografting: a prospective study.Leukemia & Lymphoma, 2004
- The 8;21 translocation in leukemogenesisOncogene, 2004
- Acute Myeloid LeukemiaHematology-American Society Hematology Education Program, 2004
- Results of an Autologous Noncryopreserved, Unmanipulated Peripheral Blood Hematopoietic Stem Cell Transplant Program: A Single-Institution, 10-Year ExperienceActa Haematologica, 2003
- Report on the first Latin American consensus conference for flow cytometric immunophenotyping of leukemiaCytometry, 1998
- Long-term survival in acute myelogenous leukemiaCancer Genetics and Cytogenetics, 1994
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958